SCHEMBL6505387

SCHEMBL6505387

CCOC(=O)CN(C)CCNC(=O)/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.58
ERBB2 P04626 7/20 0.56
KDM4E B2RXH2 1/20 0.50
GAK O14976 1/20 0.50
MAPK13 O15264 1/20 0.50
ABL1 P00519 1/20 0.50
CYP1A2 P05177 1/20 0.50
CDK1 P06493 1/20 0.50
CYP3A4 P08684 1/20 0.50
FBP1 P09467 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
SRC P12931 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
EPHB2 P29323 1/20 0.50
CYP2C19 P33261 1/20 0.50
KDR P35968 1/20 0.50
MAPK12 P53778 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505388 1.00 EGFR (0.58) EGFRERBB2KDM4EGAKMAPK13
SCHEMBL1417841 0.96 EGFR (0.60) EGFRERBB2
SCHEMBL6502203 0.96 EGFR (0.60) EGFRERBB2
SCHEMBL1417878 0.94 EGFR (0.58) EGFRERBB2KDM4EGAKMAPK13
SCHEMBL1417879 0.94 EGFR (0.58) EGFRERBB2KDM4EGAKMAPK13
SCHEMBL1417850 0.91 EGFR (0.59) EGFRERBB2KDR
SCHEMBL1417848 0.91 EGFR (0.59) EGFRERBB2KDR
SCHEMBL1417896 0.90 EGFR (0.63) EGFRERBB2KDM4EGAKMAPK13
SCHEMBL1417899 0.90 EGFR (0.63) EGFRERBB2KDM4EGAKMAPK13
SCHEMBL1418061 0.90 EGFR (0.62) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 US disclosed